Kirsten Schroer

发表

Biocatalytic ketone reduction—a powerful tool for the production of chiral alcohols—part II: whole-cell reductions

Andreas Liese, A. Liese, S. Lütz, 2007, Applied Microbiology and Biotechnology.

Evolved Aliphatic Halogenases Enable Regiocomplementary C-H Functionalization of an Added-Value Chemical.

K. Schroer, Radka Snajdrova, M. Voss, 2019, Angewandte Chemie.

Biocatalytic ketone reduction—a powerful tool for the production of chiral alcohols—part I: processes with isolated enzymes

Andreas Liese, A. Liese, S. Lütz, 2007, Applied Microbiology and Biotechnology.

Enhancement of the NAD(P)(H) Pool in Escherichia coli for Biotransformation

H. Sahm, S. Lütz, K. Schroer, 2007 .

Engineering the Pichia pastoris methanol oxidation pathway for improved NADH regeneration during whole-cell biotransformation.

Anton Glieder, A. Glieder, K. Schroer, 2010, Metabolic engineering.

Metabolomics for biotransformations: Intracellular redox cofactor analysis and enzyme kinetics offer insight into whole cell processes

M. Oldiges, S. Lütz, K. Schroer, 2009, Biotechnology and bioengineering.

Modulating Chemoselectivity in a Fe(II)/α-Ketoglutarate-Dependent Dioxygenase for the Oxidative Modification of a Nonproteinogenic Amino Acid

K. Schroer, Radka Snajdrova, Raphael Frey, 2021 .

Metabolomics: current state and evolving methodologies and tools

Marco Oldiges, Nadine Stein, M. Oldiges, 2007, Applied Microbiology and Biotechnology.

Biocatalytic assembly of chemically modified oligonucleotides

T. Peschke, F. Stanger, T. Schlama, 2022, Tetrahedron Letters.

Continuous asymmetric ketone reduction processes with recombinant Escherichia coli.

C. Wandrey, A. Liese, S. Lütz, 2007, Journal of biotechnology.

Recombinant human cytochrome P450 monooxygenases for drug metabolite synthesis.

Matthias Kittelmann, S. Lütz, K. Schroer, 2010, Biotechnology and Bioengineering.

High cell density cultivation of recombinant yeasts and bacteria under non-pressurized and pressurized conditions in stirred tank bioreactors.

J. Büchs, K. Schroer, Philip Engel, 2007, Journal of biotechnology.

Absorption, Distribution, Metabolism, and Excretion of Capmatinib (INC280) in Healthy Male Volunteers and In Vitro Aldehyde Oxidase Phenotyping of the Major Metabolite

K. Schroer, A. Meissner, G. Camenisch, 2020, Drug Metabolism and Disposition.

Definition of culture conditions for Arxula adeninivorans, a rational basis for studying heterologous gene expression in this dimorphic yeast

Thomas G. Palmen, J. Büchs, G. Kunze, 2014, Journal of Industrial Microbiology & Biotechnology.

Metabolism and Disposition of Siponimod, a Novel Selective S1P1/S1P5 Agonist, in Healthy Volunteers and In Vitro Identification of Human Cytochrome P450 Enzymes Involved in Its Oxidative Metabolism

K. Schroer, E. Legangneux, A. Meissner, 2018, Drug Metabolism and Disposition.

A Collaborative Journey towards the Late‐Stage Functionalization of Added‐Value Chemicals Using Engineered Halogenases

K. Schroer, Radka Snajdrova, N. Turner, 2022, Helvetica Chimica Acta.

Draft Genome Sequences of Three Actinobacteria Strains Presenting New Candidate Organisms with High Potentials for Specific P450 Cytochromes

V. Urlacher, Y. Vainshtein, A. Vogel, 2017, Genome Announcements.

On the Importance of Metabolic Stability to Achieve High Oral Exposures for Cyclic Peptides

T. Vorherr, M. Schaefer, K. Schroer, 2020, American Journal of Medicinal Chemistry.

Cladosporin Derivatives Obtained by Biotransformation Provide Guidance for the Focused Derivatization of this Antimalarial Lead Compound

K. Schroer, D. Hoepfner, A. Fredenhagen, 2018, Chembiochem : a European journal of chemical biology.